Pender MP - Search Results

1

Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.

Pender MP, Csurhes PA, Smith C, Douglas NL, Neller MA, Matthews KK, Beagley L, Rehan S, Crooks P, Hopkins TJ, Blum S, Green KA, Ioannides ZA, Swayne A, Aftab BT, Hooper KD, Burrows SR, Thompson KM, Coulthard A, Khanna R. Pender MP, et al. JCI Insight. 2018 Nov 15;3(22):e124714. doi: 10.1172/jci.insight.124714. JCI Insight. 2018. PMID: 30429369 Free PMC article. Clinical Trial.

2

Recent advances in the understanding, diagnosis and management of multiple sclerosis.

Pender MP. Pender MP. Aust N Z J Med. 1996 Apr;26(2):157-61. doi: 10.1111/j.1445-5994.1996.tb00878.x. Aust N Z J Med. 1996. PMID: 8744612 Review. No abstract available.

3

A study of human T-cell lines generated from multiple sclerosis patients and controls by stimulation with peptides of myelin basic protein.

Pender MP, Csurhes PA, Houghten RA, McCombe PA, Good MF. Pender MP, et al. J Neuroimmunol. 1996 Oct;70(1):65-74. doi: 10.1016/s0165-5728(96)00105-1. J Neuroimmunol. 1996. PMID: 8862136 Free article.

4

Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis.

Greer JM, Csurhes PA, Cameron KD, McCombe PA, Good MF, Pender MP. Greer JM, et al. Among authors: pender mp. Brain. 1997 Aug;120 ( Pt 8):1447-60. doi: 10.1093/brain/120.8.1447. Brain. 1997. PMID: 9278634 Free article.

5

Neurology. 4: Multiple sclerosis.

Pender MP. Pender MP. Med J Aust. 2000 Jun 5;172(11):556-62. doi: 10.5694/j.1326-5377.2000.tb124107.x. Med J Aust. 2000. PMID: 10920756 Review.

6

Surges of increased T cell reactivity to an encephalitogenic region of myelin proteolipid protein occur more often in patients with multiple sclerosis than in healthy subjects.

Pender MP, Csurhes PA, Greer JM, Mowat PD, Henderson RD, Cameron KD, Purdie DM, McCombe PA, Good MF. Pender MP, et al. J Immunol. 2000 Nov 1;165(9):5322-31. doi: 10.4049/jimmunol.165.9.5322. J Immunol. 2000. PMID: 11046067

7

Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis.

Pender MP, Csurhes PA, Wolfe NP, Hooper KD, Good MF, McCombe PA, Greer JM. Pender MP, et al. J Clin Neurosci. 2003 Jan;10(1):63-6. doi: 10.1016/s0967-5868(02)00270-9. J Clin Neurosci. 2003. PMID: 12464524 Free article.

8

Investigation of a neuronal nitric oxide synthase gene (NOS1) polymorphism in a multiple sclerosis population.

Tajouri L, Ferreira L, Ovcaric M, Curtain R, Lea R, Csurhes P, Pender MP, Griffiths LR. Tajouri L, et al. Among authors: pender mp. J Neurol Sci. 2004 Mar 15;218(1-2):25-8. doi: 10.1016/j.jns.2003.10.006. J Neurol Sci. 2004. PMID: 14759629 Free article.

9

Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls.

Greer JM, Csurhes PA, Pender MP, McCombe PA. Greer JM, et al. Among authors: pender mp. J Autoimmun. 2004 Jun;22(4):345-52. doi: 10.1016/j.jaut.2004.03.004. J Autoimmun. 2004. PMID: 15120759 Free article.

10

Investigation of an inducible nitric oxide synthase gene (NOS2A) polymorphism in a multiple sclerosis population.

Tajouri L, Martin V, Ovcaric M, Curtain RP, Lea RA, Csurhes P, Pender MP, Griffiths LR. Tajouri L, et al. Among authors: pender mp. Brain Res Bull. 2004 Jul 30;64(1):9-13. doi: 10.1016/j.brainresbull.2004.04.019. Brain Res Bull. 2004. PMID: 15275951 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190 results

Search Page